Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping

B Oosterhuis; W.J Tamminga; J Wemer; J Wieling; B Wilffert; E.P Sakiman; Lou de Leij; J.H.G. Jonkman

Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping

B Oosterhuis, W.J Tamminga, J Wemer, J Wieling, B Wilffert, E.P Sakiman, Lou de Leij, J.H.G. Jonkman

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Original language	Dutch
Title of host publication	Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems
Editors	A R Boobis, P Kremers, O Pelkonen, K Pithan
Place of Publication	Luxembourg
Publisher	Office for official publications of the european communities
Pages	197 - 200
Number of pages	4
Publication status	Published - 1999

Cite this

Oosterhuis, B., Tamminga, W. J., Wemer, J., Wieling, J., Wilffert, B., Sakiman, E. P., de Leij, L., & Jonkman, J. H. G. (1999). Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping. In A. R. Boobis, P. Kremers, O. Pelkonen, & K. Pithan (Eds.), Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems (pp. 197 - 200). Office for official publications of the european communities.

Oosterhuis, B ; Tamminga, W.J ; Wemer, J ; Wieling, J ; Wilffert, B ; Sakiman, E.P ; de Leij, Lou ; Jonkman, J.H.G. / Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping. Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems. editor / A R Boobis ; P Kremers ; O Pelkonen ; K Pithan. Luxembourg : Office for official publications of the european communities, 1999. pp. 197 - 200

@inbook{5182a1787cce414298fbb2a7b31704a1,

title = "Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping",

author = "B Oosterhuis and W.J Tamminga and J Wemer and J Wieling and B Wilffert and E.P Sakiman and {de Leij}, Lou and J.H.G. Jonkman",

year = "1999",

language = "Dutch",

pages = "197 -- 200",

editor = "Boobis, {A R} and P Kremers and O Pelkonen and K Pithan",

booktitle = "Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems",

publisher = "Office for official publications of the european communities",

}

Oosterhuis, B, Tamminga, WJ, Wemer, J, Wieling, J, Wilffert, B, Sakiman, EP, de Leij, L & Jonkman, JHG 1999, Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping. in AR Boobis, P Kremers, O Pelkonen & K Pithan (eds), Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems. Office for official publications of the european communities, Luxembourg, pp. 197 - 200.

Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping. / Oosterhuis, B; Tamminga, W.J; Wemer, J; Wieling, J; Wilffert, B; Sakiman, E.P; de Leij, Lou; Jonkman, J.H.G.

Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems. ed. / A R Boobis; P Kremers; O Pelkonen; K Pithan. Luxembourg : Office for official publications of the european communities, 1999. p. 197 - 200.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

TY - CHAP

T1 - Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping

AU - Oosterhuis, B

AU - Tamminga, W.J

AU - Wemer, J

AU - Wieling, J

AU - Wilffert, B

AU - Sakiman, E.P

AU - de Leij, Lou

AU - Jonkman, J.H.G.

PY - 1999

Y1 - 1999

M3 - Chapter

SP - 197

EP - 200

BT - Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems

A2 - Boobis, A R

A2 - Kremers, P

A2 - Pelkonen, O

A2 - Pithan, K

PB - Office for official publications of the european communities

CY - Luxembourg

ER -

Oosterhuis B, Tamminga WJ, Wemer J, Wieling J, Wilffert B, Sakiman EP et al. Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping. In Boobis AR, Kremers P, Pelkonen O, Pithan K, editors, Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems. Luxembourg: Office for official publications of the european communities. 1999. p. 197 - 200